COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,010 Articles (22,627 medRxiv, 8,383 bioRxiv)

Most recent first Previous |  Page 2734: Articles 27331-27340  | Next

Experience of quantitative SARS-CoV-2 antibody screening of health-care workers in the southern part of Kyoto city during COVID-19 peri-pandemic period
Fujita, K., Kada, S., Kanai, O., Hata, H., Odagaki, T., Satoh-Asahara, N., Tagami, T., Yasoda, A.
10.1101/2020.05.12.20098962 — Posted: 2020-05-19
Forecasting the COVID-19 Pandemic with Climate Variables for Top Five Burdening and Three South Asian Countries
Karimuzzaman, M., Afroz, S., Hossain, M. M., Rahman, A.
10.1101/2020.05.12.20099044 — Posted: 2020-05-19
Repurposing of Miglustat to inhibit the coronavirus Severe Acquired Respiratory Syndrome SARS-CoV-2
Rajasekharan, S., Milan Bonotto, R., Kazungu, Y., Nascimento Alves, L., Poggianella, M., Martinez Orellana, P., Skoko, N., Polez, S., Marcello, A.
10.1101/2020.05.18.101691 — Posted: 2020-05-18
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2.
Case, J. B., Rothlauf, P. W., Chen, R. E., Liu, Z., Zhao, H., Kim, A. S., Bloyet, L.-M., Zeng, Q., Tahan, S., Droit, L., Ilagan, M. X. G., Tartell, M. A., Amarasinghe, G. K., Henderson, J. P., Miersch, S., Ustav, M., Sidhu, S., Virgin, H. W., Wang, D., Ding, S., Corti, D., Theel, E. S., Fremont, D. H., Diamond, M. S., Whelan, S. P. J.
10.1101/2020.05.18.102038 — Posted: 2020-05-18
SARS-CoV2 infection in farmed mink, Netherlands, April 2020
Oreshkova, N., Molenaar, R.-J., Vreman, S., Harders, F., Oude Munnink, B. B., Hakze-vd Honing, R. W., Gerhards, N., Tolsma, P., Bouwstra, R., Sikkema, R., Tacken, M., de Rooij, M. M. T., Weesendorp, E., Engelsma, M., Bruschke, C., Smit, L. A. M., Koopmans, M., van der Poel, W. H. M., Stegeman, J.
10.1101/2020.05.18.101493 — Posted: 2020-05-18 Discussion: Offsite
Immunologic perturbations in severe COVID-19/SARS-CoV-2 infection
Kuri-Cervantes, L., Pampena, M. B., Meng, W., Rosenfeld, A. M., Ittner, C. A. G., Weisman, A. R., Agyekum, R., Mathew, D., Baxter, A. E., Vella, L., Kuthuru, O., Apostolidis, S., Bershaw, L., Dougherty, J., Greenplate, A. R., Pattekar, A., Kim, J., Han, N., Gouma, S., Weirick, M. E., Arevalo, C. P., Bolton, M. J., Goodwin, E. C., Anderson, E. M., Hensley, S. E., Jones, T. K., Mangalmurti, N. S., Luning Prak, E. T., Meyer, N. J., Kim, J., Betts, M. R.
10.1101/2020.05.18.101717 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Controlling the SARS-CoV-2 Spike Glycoprotein Conformation
Henderson, R., Edwards, R. J., Mansouri, K., Janowska, K., Stalls, V., Gobeil, S., Kopp, M., Hsu, A. L., Borgnia, M. J., Parks, R., Haynes, B. F., Acharya, P.
10.1101/2020.05.18.102087 — Posted: 2020-05-18 Discussion: Offsite
Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection
Minervina, A. A., Komech, E. A., Titov, A., Bensouda Koraichi, M., Rosati, E., Mamedov, I. Z., Franke, A., Efimov, G. A., Chudakov, D. M., Mora, T., Walczak, A. M., Lebedev, Y. B., Pogorelyy, M. V.
10.1101/2020.05.18.100545 — Posted: 2020-05-18 Discussion: Onsite | Offsite
Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?
Pique-Regi, R., Romero, R., Tarca, A. L., Luca, F., Xu, Y., Leng, Y., Hsu, C.-D., Gomez-Lopez, N.
10.1101/2020.05.18.101485 — Posted: 2020-05-18
Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19
Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Linty, F., Visser, R., Brinkhaus, M., Sustic, T., deTaeye, S. W., Bentlage, A. E. H., Nouta, J., Natunen, S., Koeleman, C. A. M., Sainio, S., Kootstra, N. A., Brouwer, P. J. M., Sanders, R. W., van Gils, M. J., de Bruin, S., Vlaar, A. P. J., Amsterdam UMC COVID-19 biobank study group, , Zaaijer, H. L., Wuhrer, M., van der Schoot, C. E., Vidarsson, G.
10.1101/2020.05.18.099507 — Posted: 2020-05-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).